Immunogenetic Architecture of Chronic Lymphocytic Leukemia at Early Stage: Insights from the O-CLL1 Cohort. [PDF]
Bagnara D +16 more
europepmc +1 more source
Specific Lipidomic Shifts in Chronic Lymphocytic Leukemia at Diagnosis. [PDF]
Wojnicka J +11 more
europepmc +1 more source
Clonal haematopoiesis in chronic lymphocytic leukaemia: Biology, inflammaging and clinical implications in the era of targeted therapy. [PDF]
Martino EA +12 more
europepmc +1 more source
High-Risk Chronic Lymphocytic Leukemia in a Young Adult Treated With Reduced-Dosage, Fixed-Duration Ibrutinib and Venetoclax. [PDF]
Gutierrez CLD +3 more
europepmc +1 more source
High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights. [PDF]
Parker H +18 more
europepmc +1 more source
Short and complex-Telomeres and genomes in CLL. [PDF]
Jebaraj BMC, Stilgenbauer S.
europepmc +1 more source
Efficacy of venetoclax-obinutuzumab treatment in achieving remission of acquired von Willebrand syndrome in chronic lymphocytic leukemia. [PDF]
Morelli F +5 more
europepmc +1 more source
Richter-like transformation of CLL/SLL after a temporary hold of ibrutinib: A case report. [PDF]
Chiang TL, Frater J, Cashen A.
europepmc +1 more source
Unusual Nasopharyngeal Localization of Chronic Lymphocytic Leukemia: A Case Report. [PDF]
Fadi M +4 more
europepmc +1 more source
Real‑life diagnostic and therapeutic approach to CLL/SLL in tuscany: the 2025 consensus. [PDF]
D'Amato M +17 more
europepmc +1 more source

